Orion OYJ Shares Outstanding 2017-2024 | ORINY

Orion OYJ shares outstanding for the quarter ending June 30, 2024 were 0.281B, a 0.37% increase year-over-year.

  • Orion OYJ 2023 shares outstanding were 0.281B, a 0.19% decline from 2022.
  • Orion OYJ 2022 shares outstanding were 0.281B, a 0.03% increase from 2021.
  • Orion OYJ 2021 shares outstanding were 0.281B, a 0.03% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Orion OYJ Shares Outstanding 2017-2024 | ORINY

  • Orion OYJ 2023 shares outstanding were 0.281B, a 0.19% decline from 2022.
  • Orion OYJ 2022 shares outstanding were 0.281B, a 0.03% increase from 2021.
  • Orion OYJ 2021 shares outstanding were 0.281B, a 0.03% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$88.7B
Takeda Pharmaceutical (TAK)$47.3B
Merck (MKGAF)$23.7B
Astellas Pharma (ALPMY)$21.5B
Summit Therapeutics (SMMT)$19B
Sandoz Group AG (SDZNY)$17.5B
United Therapeutics (UTHR)$15.4B
Shionogi (SGIOY)$13.3B
Neurocrine Biosciences (NBIX)$12.4B
Catalent (CTLT)$11B
Revolution Medicines (RVMD)$7.3B
Jazz Pharmaceuticals (JAZZ)$6.9B
Ionis Pharmaceuticals (IONS)$6.1B
Hikma Pharmaceuticals Plc (HKMPF)$5.7B
Madrigal Pharmaceuticals (MDGL)$5.1B
Crinetics Pharmaceuticals (CRNX)$4.2B
Corcept Therapeutics (CORT)$4.1B
Dyne Therapeutics (DYN)$3.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.7B
PTC Therapeutics (PTCT)$2.7B
Arrowhead Pharmaceuticals (ARWR)$2.5B
Catalyst Pharmaceuticals (CPRX)$2.4B
Soleno Therapeutics (SLNO)$2.1B
Recursion Pharmaceuticals (RXRX)$1.9B
Centessa Pharmaceuticals (CNTA)$1.8B
Xencor (XNCR)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.6B
Harrow (HROW)$1.5B
Cassava Sciences (SAVA)$1.5B
Ardelyx (ARDX)$1.4B